Literature DB >> 19387324

Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.

Campbell S D Roxburgh1, Jonathan M Salmond, Paul G Horgan, Karin A Oien, Donald C McMillan.   

Abstract

OBJECTIVE: To examine interrelationships between the local inflammatory response (Klintrup and Jass scores) and the systemic inflammatory response (Glasgow prognostic score [GPS]), and compare their prognostic value in patients undergoing curative resection for colorectal cancer.
BACKGROUND: Both localized peritumoral inflammatory cell infiltrate and the host systemic inflammatory response are known to have prognostic value in colorectal cancer. However, the interrelationships of biochemical and cellular components of the systemic inflammatory response and the local inflammatory response are poorly understood.
METHODS: Retrospective study of 287 patients who underwent surgery between 1997 and 2004. Data were collected from routine preoperative blood tests. Routine pathology specimens were scored according to Jass and Klintrup criteria for peritumoral infiltrate.
RESULTS: Increased Dukes stage was associated with less peritumoral infiltrate (Jass criteria: P < 0.001, Klintrup criteria: P < 0.01). Increased modified GPS (mGPS) was associated with increased circulating white cell (P < 0.01) and neutrophil (P < 0.01) counts and low lymphocyte counts (P < 0.01). Increased circulating white cell count was associated with increased neutrophil count (P < 0.001) and low-grade peritumoral infiltrate (P < 0.05, Klintrup criteria). Jass and Klintrup criteria for peritumoral infiltrate were directly associated (P < 0.001). On univariate survival analysis of patients with node-negative disease (Dukes A and B), age (P < 0.01), mGPS (P < 0.01), neutrophil count (P < 0.05), and Klintrup criteria (P < 0.05) were associated with cancer-specific survival. On multivariate survival analysis in node-negative disease, the mGPS (hazard ratio: 2.61, 95% CI: 1.27-5.35, P < 0.01) and Klintrup criteria (hazard ratio: 6.31, 95% CI: 1.40-28.44, P < 0.05) were independently associated with cancer-specific survival.
CONCLUSIONS: The results of the present study suggest low peritumoral infiltrate (Klintrup criteria) and increased systemic inflammation (mGPS criteria) are linked through the cell-mediated immune system. Furthermore, both pathologic (Klintrup) and biochemical (mGPS) measures of the inflammatory response predict survival after colorectal cancer surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19387324     DOI: 10.1097/SLA.0b013e3181a3e738

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  64 in total

1.  Colorectal cancer: sailing with a T-cell EMAST.

Authors:  Ajay Goel
Journal:  Dig Dis Sci       Date:  2011-12-20       Impact factor: 3.199

2.  Preoperative cholangitis and metastatic lymph node have a negative impact on survival after resection of extrahepatic bile duct cancer.

Authors:  Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; Dae Wook Hwang; Kyuwhan Jung; Ji Hoon Kim; Yujin Kwon; Haeryoung Kim
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

3.  Systemic inflammatory response in gastric cancer.

Authors:  Hiroharu Yamashita; Hitoshi Katai
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

4.  The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers.

Authors:  Yoshiaki Ikuta; Hiroshi Takamori; Yasuo Sakamoto; Daisuke Hashimoto; Akira Chikamoto; Hideyuki Kuroki; Kazuya Sakata; Keita Sakamoto; Hiromitsu Hayashi; Katsunori Imai; Hidetoshi Nitta; Masahiko Hirota; Keiichiro Kanemitsu; Toru Beppu; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2013-09-03       Impact factor: 3.402

5.  Prognostic significance of preoperative fibrinogen in patients with colon cancer.

Authors:  Zhen-Qiang Sun; Xiao-Na Han; Hai-Jiang Wang; Yong Tang; Ze-Liang Zhao; Yan-Li Qu; Rui-Wei Xu; Yan-Yan Liu; Xian-Bo Yu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

6.  Validation Study of Fibrinogen and Albumin Score in Esophageal Cancer Patients Who Underwent Esophagectomy: Multicenter Prospective Cohort Study.

Authors:  Satoru Matsuda; Hiroya Takeuchi; Hirofumi Kawakubo; Ryo Takemura; Yusuke Maeda; Yuki Hirata; Takuji Kaburagi; Tomohisa Egawa; Tomohiko Nishi; Masaharu Ogura; Taku Miyasho; Akihiko Okamura; Shuhei Mayanagi; Kazumasa Fukuda; Rieko Nakamura; Tomoyuki Irino; Norihito Wada; Yuko Kitagawa
Journal:  Ann Surg Oncol       Date:  2020-07-31       Impact factor: 5.344

7.  Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma.

Authors:  Hai-Jie Hu; Yan-Wen Jin; Rong-Xing Zhou; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Fei Liu; Nan-Sheng Cheng; Fu-Yu Li
Journal:  J Gastrointest Surg       Date:  2018-08-03       Impact factor: 3.452

8.  Activated systemic inflammatory response at diagnosis reduces lymph node count in colonic carcinoma.

Authors:  Rory P Kennelly; Brenda Murphy; John O Larkin; Brian J Mehigan; Paul H McCormick
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

9.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

10.  The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy.

Authors:  Mario Roselli; Vincenzo Formica; Vittore Cereda; Caroline Jochems; Jacob Richards; Italia Grenga; Augusto Orlandi; Patrizia Ferroni; Fiorella Guadagni; Jeffrey Schlom
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.